Mr. Gelernter’s practice concentrates in patent infringement litigation and other complex litigation matters. He has represented patentees and alleged infringers in numerous trials and arbitration hearings in high-stakes patent cases. In five of his cases, there were judgments or arbitration awards in favor of our clients ranging from $150 million to $702 million. He also has successfully briefed and/or argued numerous appeals in the Federal Circuit and other appellate courts.
His cases include cases for a medical device manufacturer involving coronary stents that culminated in the largest settlement of any single patent case in the United States, with our client receiving $1.7 billion in settlement. He also represented the same client in related patent cases where our client received $1.5 billion in settlement.
Mr. Gelernter also is co-General Counsel to the Firm and regularly advises lawyers and law firms on issues of professional ethics.
Representative Patent Infringement Cases
Mr. Gelernter’s work in patent infringement cases has included both trials and appeals, and has spanned a variety of technologies, ranging from medical devices to pharmaceuticals to electrical engineering and computer software.
Cases Involving Patents on Medical Devices
He has been successfully representing patentees and accused infringers in numerous patent infringement cases involving medical devices. These include a series of cases involving coronary stents that resulted in a settlement for our client of $1.7 billion, judgments for our client of $702 million and $521 million, and an arbitration award in our client's favor of $425 million.
He represented accused infringers in several cases that were resolved in our clients’ favor on summary judgment and then affirmed on appeal, including a case in which the court declared the case exceptional and awarded our client the full amount of its attorneys’ fees for defending the action.
He represented the accused infringer in the successful defense of an action involving patents on instruments used in endoscopic surgery; the verdict for our client in that case, invalidating the other side’s patents, was affirmed on appeal and was cited by The National Law Journal as one of the top defense verdicts of the year.
Cases Involving Patents on Electrical Engineering Technology and Software
Mr. Gelernter has been lead counsel for a major electronics company in cases involving digital subtraction angiography, digital data compression and interlacing imaging systems. He also has been lead counsel in cases involving patents on computer software.
He successfully represented a major electronics manufacturer in a case where the court granted summary judgment holding that the opposing parties’ patent (on speech recognition technology) was invalid as obvious.
Cases in Involving Patents on Pharmaceutical Products
He has represented major pharmaceutical companies in numerous ANDA cases, including cases involving patents on drugs for treating HIV and for reducing cholesterol levels.
Appeals in Patent Cases
Mr. Gelernter has successfully briefed and/or argued numerous appeals to the Federal Circuit, including appeals in cases where the firm won judgments for its client of $702 million and $521 million, respectively, and another case where the firm succeeded on appeal in invalidating its adversary's patent, thus avoiding damages that could have exceeded $1 billion. He also successfully briefed and argued an appeal that resulted in a decision by the Federal Circuit overturning a finding of inequitable conduct.
He successfully represented our client in two license disputes that resulted in arbitration awards to our client of $164 million and $150 million, respectively.
Mr. Gelernter advises lawyers and law firms on issues of professional ethics, and represents attorneys and law firms in disciplinary proceedings and legal malpractice actions. He also represents clients in complex commercial litigation, including a recent case in which the Third Circuit affirmed the grant of summary judgment in our client’s favor dismissing an indemnification claim.